A 50-year research journey. From laboratory to clinic.
Prior important research is not always cited, exemplified by Oswald Avery's pioneering discovery that DNA is the genetic transforming factor; it was not cited by Watson and Crick 10 years later. My first laboratory research (National Institutes of Health 1950s) resulted in the clinical development of transseptal left heart catheterization. Laboratory studies on cardiac muscle mechanics in normal and failing hearts led to the concept of afterload mismatch with limited preload reserve. At the University of California, San Diego in La Jolla (1968) laboratory experiments on coronary artery reperfusion after sustained coronary occlusion showed salvage of myocardial tissue, a potential treatment for acute myocardial infarction proven in clinical trials of thrombolysis 14 years later. Among 60 trainees who worked with me in La Jolla, one-third were Japanese and some of their important laboratory experiments are briefly recounted, beginning with Sasayama, Tomoike and Shirato in the 1970 s. Recently, we developed a method for cardiac gene transfer, and subsequently we showed that gene therapy for the defect in cardiomyopathic hamsters halted the progression of advanced disease. Cardiovascular research and medicine are producing continuing advances in technologies for gene transfer and embryonic stem cell transplantation, targeting of small molecules, and tissue and organ engineering.
Ross
John
J
Department of Medicine, Division of Cardiology, University of California San Diego School of Medicine, La Jolla, CA 92093, USA. jlross@ucsd.edu
D000818:Animals; D035843:Biomedical Research / Q000639:trends*; D006328:Cardiac Catheterization / Q000639:trends; D009202:Cardiomyopathies / Q000628:therapy*; D004195:Disease Models, Animal; D015316:Genetic Therapy / Q000639:trends; D006801:Humans; D033581:Stem Cell Transplantation / Q000639:trends; D015912:Thrombolytic Therapy / Q000639:trends